Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TALIMOGENE LAHERPAREPVEC vs TARLATAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TALIMOGENE LAHERPAREPVEC vs TARLATAMAB: Safety Overview

Metric	TALIMOGENE LAHERPAREPVEC	TARLATAMAB
Total FAERS Reports	1,475	145
Deaths Reported	164	49
Death Rate	11.1%	33.8%
Hospitalizations	286	52
Average Patient Age	66.7 yrs	62.7 yrs
% Female Patients	48.3%	34.0%
Manufacturer	Amgen Inc	N/A
Route	INTRALESIONAL	N/A